A study to look at how safe different doses of the study medicine - DCDS0780A - were for patients with non-Hodgkin’s Lymphoma that involved B cells

A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Cancer
Non Hodgkin Lymphoma (NHL)

Results
Download
Print

Study results

LPS GO29687 Final Results March 2020 English (PDF, 0.1 MB)

LPS GO29687 Final Results March 2020 Spanish (PDF, 0.1 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A study to look at how safe different doses of the study medicine - DCDS0780A - were for patients with non-Hodgkin’s Lymphoma that involved B cells

Study results

LPS GO29687 Final Results March 2020 English (PDF, 0.1 MB)

LPS GO29687 Final Results March 2020 Spanish (PDF, 0.1 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

Directly contact Roche for questions

Contact the hospital directly

Thank you

Something went wrong

Request a call back

Find participating medical centers and current study status in each of them

A study to look at how safe different doses of the study medicine - DCDS0780A - were for patients with non-Hodgkin’s Lymphoma that involved B cells

For the latest version of this information please go to www.forpatients.roche.com